You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Olaparib

Showing 1 - 25 of 385
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Bengbu (The test olaparib tablet (T), The reference olaparib tablet (R))

Completed
  • Neoplasms
  • The test olaparib tablet (T)
  • The reference olaparib tablet (R)
  • Bengbu, Anhui, China
    The First Affiliated Hospital of Bengbu Medical College
May 15, 2023

Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Modena (Olaparib 150 MG)

Recruiting
  • Advanced Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Olaparib 150 MG
  • Modena, Italy
    Aou Modena
Oct 5, 2023

Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jun 2, 2023

Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

Not yet recruiting
  • Ovarian Cancer
  • Olaparib tablet
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Nov 1, 2023

Carcinoma, Ovarian Epithelial Trial in San Fermo Della Battaglia, Padova (Olaparib, Bevacizumab)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • San Fermo Della Battaglia, Como, Italy
  • +1 more
Nov 2, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

Recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Aurora, Colorado
  • +2 more
Jan 4, 2023

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Olaparib
  • Aurora, Colorado
    University of Colorado Hospital
May 30, 2023

Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

Recruiting
  • Extensive-stage Small Cell Lung Cancer
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 27, 2023

PRostate Olaparib Real World Evidence Study

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Sep 4, 2023

    Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)

    Not yet recruiting
    • Cancer
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Oct 30, 2023

    Pancreatic Acinar Cell Carcinoma Trial run by the National Cancer Institute (NCI) (Olaparib)

    Recruiting
    • Pancreatic Acinar Cell Carcinoma
    • Olaparib
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt

    Not yet recruiting
    • Advanced Ovarian Cancer
    • None (Observational Study)
    • (no location specified)
    Mar 8, 2023

    Prostate Cancer Aggressiveness, Prostate Carcinoma Trial in Houston (Cabazitaxel, Carboplatin, Prednisone 5Mg)

    Active, not recruiting
    • Prostate Cancer Aggressiveness
    • Prostate Carcinoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 5, 2022

    Sarcoma, Sarcoma Metastatic Trial in Ann Arbor (Olaparib, Trabectedin)

    Active, not recruiting
    • Sarcoma
    • Sarcoma Metastatic
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Dec 20, 2022

    Cancer Trial in Amsterdam, Nijmegen, Rotterdam (Olaparib, Cobicistat)

    Recruiting
    • Cancer
    • Amsterdam, Netherlands
    • +2 more
    Oct 21, 2022

    Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • +2 more
    • (no location specified)
    Jan 17, 2023

    Metastatic Breast Cancer Trial in Taipei City, Taipei, Yuanlin (Olaparib, Chemotherapy drug)

    Recruiting
    • Metastatic Breast Cancer
    • Olaparib
    • Chemotherapy drug
    • Taipei City, Please Select, Taiwan
    • +2 more
    Nov 27, 2022

    Breast Cancer Trial in Los Angeles (Pembrolizumab, Olaparib)

    Active, not recruiting
    • Breast Cancer
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Feb 1, 2023

    Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

    Recruiting
    • Urothelial Carcinoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in United States (Olaparib Pill 50 mg, Olaparib Pill 100 mg, Olaparib

    Active, not recruiting
    • Small-cell Lung Cancer
    • Small Cell Lung Carcinoma
    • Olaparib Pill 50 mg
    • +6 more
    • Miami, Florida
    • +8 more
    Sep 14, 2022

    Breast Cancer Trial in Worldwide (Neoadjuvant Olaparib monotherapy group, Neoadjuvant combination therapy with olaparib plus

    Not yet recruiting
    • Breast Cancer
    • Neoadjuvant Olaparib monotherapy group
    • Neoadjuvant combination therapy with olaparib plus durvalumab
    • Wien, Austria
    • +6 more
    Aug 10, 2022

    Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

    Active, not recruiting
    • Colorectal Cancer
    • Temozolomide + Olaparib
    • New Haven, Connecticut
      Yale New Haven Hospital
    Aug 17, 2022

    Metastatic Pancreatic Cancer Trial in Barcelona, La Coruña, Santander (olaparib+durvalumab)

    Recruiting
    • Metastatic Pancreatic Cancer
    • Barcelona, Spain
    • +2 more
    Dec 29, 2022

    Prostate Cancer Trial in Lexington (biological, drug, radiation)

    Not yet recruiting
    • Prostate Cancer
    • Pembrolizumab
    • +3 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 3, 2022

    Advanced Solid Tumor, Metastatic Solid Tumor Trial (ART6043, Olaparib, Talazoparib)

    Not yet recruiting
    • Advanced Solid Tumor
    • Metastatic Solid Tumor
    • (no location specified)
    Jun 1, 2023